Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke

被引:6
作者
Zhan, Yongyi [1 ]
Dai, Yue [1 ]
Ding, Zhejing [1 ]
Lu, Mingtian [1 ]
He, Zehua [1 ]
Chen, Zhengwei [1 ]
Liu, Yongkang [1 ]
Li, Zhongliang [1 ]
Cheng, Guangsen [1 ]
Peng, Shaojun [2 ]
Liu, Yu [1 ]
机构
[1] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Intervent Med Ctr, Cerebrovasc Dis Dept,Zhuhai Clin Med Coll, Zhuhai, Peoples R China
[2] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Inst Translat Med, Zhuhai Clin Med Coll, Zhuhai, Peoples R China
基金
中国国家自然科学基金;
关键词
ischemic stroke; stimuli-responsive; nanomedicine; micro-environment; drug delivery; TARGETED DELIVERY; THROMBOLYSIS; PREVENTION; MANAGEMENT; NANOPARTICLES; NANOCARRIERS; THROMBECTOMY; ASSOCIATION; STRATEGY; THERAPY;
D O I
10.3389/fbioe.2023.1329959
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ischemic stroke (IS) refers to local brain tissue necrosis which is caused by impaired blood supply to the carotid artery or vertebrobasilar artery system. As the second leading cause of death in the world, IS has a high incidence and brings a heavy economic burden to all countries and regions because of its high disability rate. In order to effectively treat IS, a large number of drugs have been designed and developed. However, most drugs with good therapeutic effects confirmed in preclinical experiments have not been successfully applied to clinical treatment due to the low accumulation efficiency of drugs in IS areas after systematic administration. As an emerging strategy for the treatment of IS, stimuli-responsive nanomedicines have made great progress by precisely delivering drugs to the local site of IS. By response to the specific signals, stimuli-responsive nanomedicines change their particle size, shape, surface charge or structural integrity, which enables the enhanced drug delivery and controlled drug release within the IS tissue. This breakthrough approach not only enhances therapeutic efficiency but also mitigates the side effects commonly associated with thrombolytic and neuroprotective drugs. This review aims to comprehensively summarize the recent progress of stimuli-responsive nanomedicines for the treatment of IS. Furthermore, prospect is provided to look forward for the better development of this field.
引用
收藏
页数:18
相关论文
共 96 条
[1]   Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging [J].
Albers, G. W. ;
Marks, M. P. ;
Kemp, S. ;
Christensen, S. ;
Tsai, J. P. ;
Ortega-Gutierrez, S. ;
McTaggart, R. A. ;
Torbey, M. T. ;
Kim-Tenser, M. ;
Leslie-Mazwi, T. ;
Sarraj, A. ;
Kasner, S. E. ;
Ansari, S. A. ;
Yeatts, S. D. ;
Hamilton, S. ;
Mlynash, M. ;
Heit, J. J. ;
Zaharchuk, G. ;
Kim, S. ;
Carrozzella, J. ;
Palesch, Y. Y. ;
Demchuk, A. M. ;
Bammer, R. ;
Lavori, P. W. ;
Broderick, J. P. ;
Lansberg, M. G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08) :708-718
[2]   Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies [J].
Alkaff, Syed Abdullah ;
Radhakrishnan, Krishna ;
Nedumaran, Anu Maashaa ;
Liao, Ping ;
Czarny, Bertrand .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 :445-464
[3]   Assessment of the Predictive Validity of Etiologic Stroke Classification [J].
Arsava, E. Murat ;
Helenius, Johanna ;
Avery, Ross ;
Sorgun, Mine H. ;
Kim, Gyeong-Moon ;
Pontes-Neto, Octavio M. ;
Park, Kwang Yeol ;
Rosand, Jonathan ;
Vangel, Mark ;
Ay, Hakan .
JAMA NEUROLOGY, 2017, 74 (04) :419-426
[4]   Ultrasound-Responsive Systems as Components for Smart Materials [J].
Athanassiadis, Athanasios G. ;
Ma, Zhichao ;
Moreno-Gomez, Nicolas ;
Melde, Kai ;
Choi, Eunjin ;
Goyal, Rahul ;
Fischer, Peer .
CHEMICAL REVIEWS, 2022, 122 (05) :5165-5208
[5]   A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke [J].
Berkhemer, O. A. ;
Fransen, P. S. S. ;
Beumer, D. ;
van den Berg, L. A. ;
Lingsma, H. F. ;
Yoo, A. J. ;
Schonewille, W. J. ;
Vos, J. A. ;
Nederkoorn, P. J. ;
Wermer, M. J. H. ;
van Walderveen, M. A. A. ;
Staals, J. ;
Hofmeijer, J. ;
van Oostayen, J. A. ;
Nijeholt, G. J. Lycklama A. ;
Boiten, J. ;
Brouwer, P. A. ;
Emmer, B. J. ;
de Bruijn, S. F. ;
van Dijk, L. C. ;
Kappelle, L. J. ;
Lo, R. H. ;
Van Dijk, E. J. ;
de Vries, J. ;
de Kort, P. L. M. ;
van Rooij, W. J. J. ;
van den Berg, J. S. P. ;
van Hasselt, B. A. A. M. ;
Aerden, L. A. M. ;
Dallinga, R. J. ;
Visser, M. C. ;
Bot, J. C. J. ;
Vroomen, P. C. ;
Eshghi, O. ;
Schreuder, T. H. C. M. L. ;
Heijboer, R. J. J. ;
Keizer, K. ;
Tielbeek, A. V. ;
den Hertog, H. M. ;
Gerrits, D. G. ;
van den Berg-Vos, R. M. ;
Karas, G. B. ;
Steyerberg, E. W. ;
Flach, H. Z. ;
Marquering, H. A. ;
Sprengers, M. E. S. ;
Jenniskens, S. F. M. ;
Beenen, L. F. M. ;
van den Berg, R. ;
Koudstaal, P. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (01) :11-20
[6]   Photothermal-Activatable Liposome Carrying Tissue Plasminogen Activator for Photoacoustic Image-Guided Ischemic Stroke Treatment [J].
Cai, Xiaolei ;
Bandla, Aishwarya ;
Wang, Can ;
Liu, Yu-Hang ;
Chuan, Chan Kim ;
Xu, Yu ;
Liu, Xingang ;
Xu, Shidang ;
Wu, Wenbo ;
Thakor, Nitish, V ;
Liu, Bin .
SMALL STRUCTURES, 2022, 3 (02)
[7]   Associations of behaviors, biological phenotypes and cardiovascular health with risks of stroke and stroke subtypes: A prospective cohort study [J].
Cao, Zhi ;
Li, Shu ;
Yang, Hongxi ;
Xu, Chenjie ;
Zhang, Yuan ;
Yang, Xueli ;
Yan, Tao ;
Liu, Tong ;
Wang, Yaogang .
ECLINICALMEDICINE, 2021, 33
[8]   Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and infl ammation [J].
Chamorro, Angel ;
Dirnagl, Ulrich ;
Urra, Xabier ;
Planas, Anna M. .
LANCET NEUROLOGY, 2016, 15 (08) :869-881
[9]   Initial establishment of a stroke management model in China: 10 years (2011-2020) of Stroke Prevention Project Committee, National Health Commission [J].
Chao, Bao-Hua ;
Tu, Wen-Jun ;
Wang, Long-De .
CHINESE MEDICAL JOURNAL, 2021, 134 (20) :2418-2420
[10]   Advances in nanomaterial-based targeted drug delivery systems [J].
Cheng, Xiaoxiao ;
Xie, Qirong ;
Sun, Yang .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11